TPG Capital Asia takes majority stake in iNova Pharmaceuticals

TPG Capital Asia takes majority stake in iNova Pharmaceuticals

US private equity firm TPG Inc has completed its majority investment in iNova Pharmaceuticals, an independent consumer healthcare and medicine products company in the Asia-Pacific, alongside co-investors, according to an announcement.

The transaction value was not disclosed. Existing iNova investor, Pacific Equity Partners (PEP), has re-invested from its new fund as a minority stakeholder.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter